Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Jiaqi Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-2128-0109; OpenAlex author ID A5004231367. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2026: 3 papers

Papers 3

  1. DCAF13 is associated with pancreatic ductal adenocarcinoma progression and p53-related signaling in TP53-mutant cells. Last author DOI 10.1016/j.bbrc.2026.154207↗
  2. Evaluation of translational potential of mRNA vaccine candidate antigens for pancreatic cancer: a systematic review based on clinical evidence and stratified p… First author DOI 10.3389/fimmu.2026.1803792↗
  3. PLA-THF-PEG nanoparticles Co-encapsulating AV3 and KH3 for synergistic pancreatic cancer therapy via stromal remodeling and metabolic inhibition. Co-author DOI 10.3389/fphar.2026.1723694↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuzhe Xue · 2 shared papers, 2026 · strength 0.65
  2. Xiaorong Liu · 1 shared paper, 2026 · strength 0.36
  3. Fenfen Jiang · 1 shared paper, 2026 · strength 0.36
  4. Xuesong He · 1 shared paper, 2026 · strength 0.29
  5. Xiaofang Fan · 1 shared paper, 2026 · strength 0.28
  6. Bin Wu · 1 shared paper, 2026 · strength 0.28
  7. Lingyu Hu · 1 shared paper, 2026 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.